78 related articles for article (PubMed ID: 15279341)
1. Endometrial abnormalities in postmenopausal breast cancer patients.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2004 Jun; 87(6):636-40. PubMed ID: 15279341
[TBL] [Abstract][Full Text] [Related]
2. Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study.
Sinawat S; Chiyabutra T
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S59-63. PubMed ID: 21218592
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen.
Sinawat S; Chiyabutra T; Kleabkaew P
Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591
[TBL] [Abstract][Full Text] [Related]
4. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
[TBL] [Abstract][Full Text] [Related]
5. [Transvaginal sonography of the postmenopausal endometrium].
Curcić A; Segedi D; Belopavlović Z; Petrović D
Med Pregl; 2000; 53(1-2):59-63. PubMed ID: 10953553
[TBL] [Abstract][Full Text] [Related]
6. The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients.
Kavak ZN; Binöz S; Ceyhan N; Pekin S
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):604-7. PubMed ID: 10929963
[TBL] [Abstract][Full Text] [Related]
7. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
[TBL] [Abstract][Full Text] [Related]
8. [Endometrial measurement by transvaginal sonography in postmenopausal bleeding].
Lewin A; Gabis L; Ushakov F; Anteby SA
Harefuah; 1996 May; 130(10):662-8, 728. PubMed ID: 8794653
[TBL] [Abstract][Full Text] [Related]
9. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.
Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J
Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237
[TBL] [Abstract][Full Text] [Related]
10. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of endometrial assessment by transvaginal ultrasonography in patients with postmenopausal bleeding].
Li S; Gao S
Zhonghua Fu Chan Ke Za Zhi; 1997 Jan; 32(1):31-3. PubMed ID: 9596868
[TBL] [Abstract][Full Text] [Related]
12. Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women.
Cohen I; Azaria R; Shapira J; Yigael D; Tepper R
Cancer; 2002 Jun; 94(12):3101-6. PubMed ID: 12115340
[TBL] [Abstract][Full Text] [Related]
13. [Rating of transvaginal sonography in the evaluation of postmenopausal bleeding].
Gerber B; Krause A; Kuelz T; Quasmeh A; Reimer T; Friese K
Zentralbl Gynakol; 1999; 121(3):143-8. PubMed ID: 10209857
[TBL] [Abstract][Full Text] [Related]
14. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of endometrial abnormalities in breast cancer patients taking tamoxifen: the need for gynaecologic surveillance.
Sinawat S; Chiyabutra T
Asian Pac J Cancer Prev; 2004; 5(2):183-7. PubMed ID: 15244522
[TBL] [Abstract][Full Text] [Related]
16. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients.
Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I
Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946
[TBL] [Abstract][Full Text] [Related]
17. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.
Smith-Bindman R; Weiss E; Feldstein V
Ultrasound Obstet Gynecol; 2004 Oct; 24(5):558-65. PubMed ID: 15386607
[TBL] [Abstract][Full Text] [Related]
18. Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients.
Cohen I; Rosen DJ; Shapira J; Cordoba M; Gilboa S; Altaras MM; Yigael D; Beyth Y
Gynecol Oncol; 1994 Feb; 52(2):185-90. PubMed ID: 8314137
[TBL] [Abstract][Full Text] [Related]
19. [Use of hysteroscopy, ultrasonography and selected hormonal tests for diagnosis of hyperplastic endometrial changes].
Bedner R
Ann Acad Med Stetin; 2001; 47():89-105. PubMed ID: 12514904
[TBL] [Abstract][Full Text] [Related]
20. Long-term transvaginal ultrasonographic endometrial follow-up in postmenopausal breast cancer patients with tamoxifen treatment.
Nahari C; Tepper R; Beyth Y; Flex D; Figer A; Cohen I
Gynecol Oncol; 1999 Aug; 74(2):222-6. PubMed ID: 10419735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
